一、生活方式干预
二、HTG药物治疗
参考资料(可上下滑动查看) [1] 高甘油三酯血症临床管理多学科专家共识工作组. 高甘油三酯血症临床管理多学科专家共识[J]. 中国循环杂志, 2023, 38(6): 621-633. [2]慢性肾脏病高甘油三酯血症管理专家共识专家组. 慢性肾脏病高甘油三酯血症管理专家共识[J]. 中华肾脏病杂志, 2022, 38(8): 760-770. [3] Virani SS, et al., (2021). 2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology Solution Set Oversight Committee[J]. J Am Coll Cardiol, DOI:10.1016/j.jacc.2021.06.011. [4] St-Onge MP, et al., (2017). Meal timing and frequency: implications for cardiovascular disease prevention: a scientific statement from the American Heart Association[J]. Circulation, DOI:10.1161/CIR.0000000000000476. [5] Tardif JC, et al., (2022). Apolipoprotein C-- reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk[J]. Eur Heart J, DOI: 10.1093/eurheartj/ehab820. [6] Bergmark BA, et al., (2022). Effect of vupanorsen on non-high-density lipoprotein cholesterol levels in statin-treated patients with elevated cholesterol: TRANSLATETIMI 70[J]. Circulation, DOI: 10.1161/CIRCULATIONAHA.122.059266. [7] Simya Vinaya, 等. 高甘油三酯血症的管理[J]. 英国医学杂志中文版, 2021, 24(5): 272-286. [8] 刘华祯, 等. 自身抗体与高甘油三酯血症[J]. 中华临床营养杂志, 2019, 27(6): 389-392. |
|